Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun medicine A humanized monoclonal antibody used in the treatment of multiple sclerosis and Crohn's disease.

Etymologies

from Wiktionary, Creative Commons Attribution/Share-Alike License

Ad hoc prefix + -li- + -zu- + -mab

Examples

  • Also known as natalizumab, Tysabri showed great promise in early trials; it reduced the frequency of relapses by 66 percent and looked to be twice as effective as alternatives in preventing flare-ups of the disease over a year’s time, representing a significant improvement over other MS therapies.

    The Autoimmune Epidemic

  • Also known as natalizumab, Tysabri showed great promise in early trials; it reduced the frequency of relapses by 66 percent and looked to be twice as effective as alternatives in preventing flare-ups of the disease over a year’s time, representing a significant improvement over other MS therapies.

    The Autoimmune Epidemic

  • Elan's breakthrough selective adhesion molecule inhibitor Tysabri® natalizumab is approved for the treatment multiple sclerosis and Crohn's disease.

    Xoma and Elan: A Tale of Two Mismanaged Biotech Companies, Part 2 - Seeking Alpha

  • Earlier work by Steinman, proceeding from animal models to clinical trials, led to the development of another blockbuster multiple-sclerosis drug, natalizumab, marketed under the trade name Tysabri.

    THE MEDICAL NEWS

  • Accutane Side Effects Years After Stopping que amazed phar toda la dosis, depigmentation un declaration de natalizumab tourettes chlorphenesin vaso, zyrtecabatacept suavemente y stomache de inmediato.

    Wii-volution

  • Earlier work by Steinman, proceeding from animal models to clinical trials, led to the development of another blockbuster multiple-sclerosis drug, natalizumab, marketed under the trade name Tysabri.

    THE MEDICAL NEWS

  • Earlier work by Steinman, proceeding from animal models to clinical trials, led to the development of another blockbuster multiple-sclerosis drug, natalizumab, marketed under the trade name Tysabri.

    PhysOrg.com - latest science and technology news stories

  • However, US FDA believes that the clinical benefits of natalizumab (Tysabri) continue to outweigh the potential risks.

    DWS Full News Feed

  • Earlier work by Steinman, proceeding from animal models to clinical trials, led to the development of another blockbuster multiple-sclerosis drug, natalizumab, marketed under the trade name Tysabri.

    PhysOrg.com - latest science and technology news stories

  • Just months after receiving FDA approval, natalizumab, a medication for the treatment of multiple sc ...

    THE MEDICAL NEWS

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.